High-Intensity-Interval-Training in Geriatric Rehabilitation - A Feasibility Study

March 2, 2021 updated by: Michael Kruesi, Klinik Valens
Study with Patients (40-60 participants) above the age of 65. There will be a comparison of regular training on ergometer (10 trainings within 2 weeks, 40 min each) to high intensity interval training on ergometer (6 trainings within 2 weeks, 25 min each). At the beginning and at the end will be a spiroergometer to measure the individual limits and vO2max, which will be compared amongst the two groups. To receive a subjective feedback, there will be a series of questionnaires at the beginning, after one week and at the end. The goal of this study is to get more information about whether a HII-Training is feasible with elderly patients and whether they can profit form it.

Study Overview

Status

Active, not recruiting

Conditions

Intervention / Treatment

Study Type

Interventional

Enrollment (Anticipated)

60

Phase

  • Not Applicable

Contacts and Locations

This section provides the contact details for those conducting the study, and information on where this study is being conducted.

Study Locations

  • Switzerland
      • Walenstadtberg, Switzerland
        • Rehazentrum Walenstadtberg

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Eligibility Criteria

Ages Eligible for Study

65 years and older (Older Adult)

Accepts Healthy Volunteers

Yes

Genders Eligible for Study

All

Description

Inclusion Criteria:

  • cardiopulmonal resilient
  • able to sit on a ergometer
  • knowledge of German written and spoken

Exclusion Criteria:

  • Severe cardiopulmonary restriction (LVEF <30%, conduction abnormalities from AV block IIb or higher)
  • Absolute cardiopulmonary contraindications (acute coronary syndrome, unstable AP -> not capable of rehabilitation), uncompensated heart failure (dyspnea at rest, orthopnea, severe edema)
  • No ischemic events (cardiac, cerebral, peripheral) within the last 3 months
  • Severe pneumatological underlying disease: COPD GOLD 3 and higher or status after exacerbation within the last 2 weeks, Asthma grade 4
  • Dyalisis reliant
  • Severe psychiatric disorder (severe psychosis, severe depression)
  • Distinct dementia

Study Plan

This section provides details of the study plan, including how the study is designed and what the study is measuring.

How is the study designed?

Design Details

  • Primary Purpose: Basic Science
  • Allocation: Randomized
  • Interventional Model: Parallel Assignment
  • Masking: None (Open Label)

Arms and Interventions

Participant Group / Arm
Intervention / Treatment
No Intervention: Control Group
Patients will participate in regular training units
Active Comparator: HIIT Group
Patients will participate in high intensity interval training
Other: High Intensity Interval Training
Training for 25 min with four 1 minute intervals when participants exercise up to 80% of their individual limits.

What is the study measuring?

Primary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Will there be a change in outcome of individuals vO2max?
Time Frame: 2 Weeks
Measurement of vO2max with spiroergometer at the beginning and end
2 Weeks
Is a High intensity interval training feasible with elderly patients in rehabilitation?
Time Frame: 1 Day
Questionnaire (Clinic-intern questionnaire) amongst the involved personal
1 Day

Secondary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Will there be a change in subjective quality of life?
Time Frame: 2.5 Weeks
Questionnaires (PROMIS-10, EQ-5D) amongst the participants
2.5 Weeks

Collaborators and Investigators

This is where you will find people and organizations involved with this study.

Sponsor

Klinik Valens

Study record dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Major Dates

Study Start (Actual)

July 30, 2019

Primary Completion (Actual)

September 30, 2020

Study Completion (Anticipated)

December 15, 2021

Study Registration Dates

First Submitted

June 16, 2019

First Submitted That Met QC Criteria

July 17, 2019

First Posted (Actual)

July 18, 2019

Study Record Updates

Last Update Posted (Actual)

March 3, 2021

Last Update Submitted That Met QC Criteria

March 2, 2021

Last Verified

March 1, 2021

More Information

Terms related to this study

Additional Relevant MeSH Terms

Other Study ID Numbers

  • KLV-BA-2019-1

Drug and device information, study documents

Studies a U.S. FDA-regulated drug product

No

Studies a U.S. FDA-regulated device product

No

This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.

Clinical Trials on Rehabilitation

Clinical Trials on High Intensity Interval Training

Search Similar Trials

Sponsors and Collaborators

Medical Conditions

Drug Interventions

CROs by country

CROs in Mozambique

Conditions

Rare Diseases

Drug Interventions

Dietary Supplements

Sponsor/Collaborators

Locations

Subscribe